Development of a multiplexed fluorescent immunoassay for the quantitation of antibody responses to group A streptococci

Journal of Immunological Methods

Volumn 316, Issue 1-2, 2006, Pages 97-106

  Martins, Thomas B ^a   Augustine, Nancy H ^a,b   Hill, Harry R ^a,b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody quantitation; Antigen coupling; Group A Streptococcus; Multiplex assay; Non specific binding

Indexed keywords

BUFFER; CROSS REACTING ANTIGEN; DILUENT; MICROSPHERE; MONOCLONAL ANTIBODY; STREPTOCOCCUS ANTIGEN;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; IMMUNE STATUS; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; MEDICAL RESEARCH; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SENSITIVITY ANALYSIS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION;

ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; FLOW CYTOMETRY; HUMANS; MICROSPHERES; RHEUMATIC FEVER; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS SP. 'GROUP A';

EID: 33750006821     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2006.08.007     Document Type: Article

References (39)

1. Alsaeid K., and Majeed H.A. Acute rheumatic fever: diagnosis and treatment. Pediatr. Ann. 27 (1998) 295
2. Bessen D.E., Veasy L.G., Hill H.R., Augustine N.H., and Fischetti V.A. Serologic evidence for a class I group A streptococcal infection among rheumatic fever patients. J. Infect. Dis. 172 (1995) 1608
3. Bisno A.L. Group A streptococcal infections and acute rheumatic fever. N. Engl. J. Med. 325 (1991) 783
4. Bisno A.L., Brito M.O., and Collins C.M. Molecular basis of group A streptococcal virulence. Lancet, Infect. Dis. 3 (2003) 191
5. Bronze M.S., and Dale J.B. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J. Immunol. 151 (1993) 2820
6. Cairns L.M. The immunology of rheumatic fever. N. Z. Med. J. 101 (1988) 388
7. Chmouryguina I., Suvorov A., Ferrieri P., and Cleary P.P. Conservation of the C5a peptidase genes in group A and B streptococci. Infect. Immun. 64 (1996) 2387
8. Church A.J., Cardoso F., Dale R.C., Lees A.J., Thompson E.J., and Giovannoni G. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology 59 (2002) 227
9. Church A.J., Dale R.C., Cardoso F., Candler P.M., Chapman M.D., Allen M.L., Klein N.J., Lees A.J., and Giovannoni G. CSF and serum immune parameters in Sydenham's chorea: evidence of an autoimmune syndrome?. J. Neuroimmunol. 136 (2003) 149
10. Cleary P.P., Prahbu U., Dale J.B., Wexler D.E., and Handley J. Streptococcal C5a peptidase is a highly specific endopeptidase. Infect. Immun. 60 (1992) 5219
11. Cunningham M.W. Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis. Am. J. Pathol. 159 (2001) 5
12. Fischetti V.A. Streptococcal M protein. Sci. Am. 264 (1991) 58
13. Fischetti V.A. Purification of streptococcal M protein. Methods Enzymol. 235 (1994) 286
14. Friedman J., van de Rijn I., Ohkuni H., Fischetti V.A., and Zabriskie J.B. Immunological studies of post-streptococcal sequelae. Evidence for presence of streptococcal antigens in circulating immune complexes. J. Clin. Invest. 74 (1984) 1027
15. Fulton R.J., McDade R.L., Smith P.L., Kienker L.J., and Kettman Jr. J.R. Advanced multiplexed analysis with the FlowMetrix system. Clin. Chem. 43 (1997) 1749
16. Gibofsky A., and Zabriskie J.B. Rheumatic fever and poststreptococcal reactive arthritis. Curr. Opin. Rheumatol. 7 (1995) 299
17. Gibofsky A., Khanna A., Suh E., and Zabriskie J.B. The genetics of rheumatic fever: relationship to streptococcal infection and autoimmune disease. J. Rheumatol., Suppl. 30 (1991) 1
18. Gray B.M. ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes. J. Immunol. Methods 28 (1979) 187
19. Ji Y., McLandsborough L., Kondagunta A., and Cleary P.P. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect. Immun. 64 (1996) 503
20. Jones K.F., Whitehead S.S., Cunningham M.W., and Fischetti V.A. Reactivity of rheumatic fever and scarlet fever patients' sera with group A streptococcal M protein, cardiac myosin, and cardiac tropomyosin: a retrospective study. Infect. Immun. 68 (2000) 7132
21. Kaplan E.L., Ferrieri P., and Wannamaker L.W. Comparison of the antibody response to streptococcal cellular and extracellular antigens in acute pharyngitis. J. Pediatr. 84 (1974) 21
22. Khanna A.K., Nomura Y., Fischetti V.A., and Zabriskie J.B. Antibodies in the sera of acute rheumatic fever patients bind to human cardiac tropomyosin. J. Autoimmun. 10 (1997) 99
23. Kirvan C.A., Swedo S.E., Heuser J.S., and Cunningham M.W. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat. Med. 9 (2003) 914
24. Lymbury R.S., Olive C., Powell K.A., Good M.F., Hirst R.G., LaBrooy J.T., and Ketheesan N. Induction of autoimmune valvulitis in Lewis rats following immunization with peptides from the conserved region of group A streptococcal M protein. J. Autoimmun. 20 (2003) 211
25. Martins T.B., Pasi B.M., Pickering J.W., Jaskowski T.D., Litwin C.M., and Hill H.R. Determination of cytokine responses using a multiplexed fluorescent microsphere immunoassay. Am. J. Clin. Pathol. 118 (2002) 346
26. Martins T.B., Pasi B.M., Litwin C.M., and Hill H.R. Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum. Clin. Diagn. Lab. Immunol. 11 (2004) 325
27. O′Connor S.P., and Cleary P.P. Localization of the streptococcal C5a peptidase to the surface of group A streptococci. Infect. Immun. 53 (1986) 432
28. O′Connor S.P., Darip D., Fraley K., Nelson C.M., Kaplan E.L., and Cleary P.P. The human antibody response to streptococcal C5a peptidase. J. Infect. Dis. 163 (1991) 109
29. Quinn A., Ward K., Fischetti V.A., Hemric M., and Cunningham M.W. Immunological relationship between the class I epitope of streptococcal M protein and myosin. Infect. Immun. 66 (1998) 4418
30. Quinn A., Kosanke S., Fischetti V.A., Factor S.M., and Cunningham M.W. Induction of autoimmune valvular heart disease by recombinant streptococcal m protein. Infect. Immun. 69 (2001) 4072
31. Salvadori L.G., Blake M.S., McCarty M., Tai J.Y., and Zabriskie J.B. Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies. J. Infect. Dis. 171 (1995) 593
32. Shet A., and Kaplan E.L. Clinical use and interpretation of group A streptococcal antibody tests: a practical approach for the pediatrician or primary care physician. Pediatr. Infect. Dis. J. 21 (2002) 420
33. Shet A., Kaplan E.L., Johnson D.R., and Cleary P.P. Immune response to group A streptococcal C5a peptidase in children: implications for vaccine development. J. Infect. Dis. 188 (2003) 809
34. Shet A., Kaplan E., Johnson D., and Cleary P.P. Human immunogenicity studies on group A streptococcal C5a peptidase (SCPA) as a potential vaccine against group A streptococcal infections. Indian. J. Med. Res. 119 (2004) 95
35. Staros J.V., Wright R.W., and Swingle D.M. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal. Biochem. 156 (1986) 220
36. Todome Y., Ohkuni H., Yokomuro K., Kimura Y., Hamada S., Johnston K.H., and Zabriskie J.B. Enzyme-linked immunosorbent assay of antibody to group A Streptococcus-specific C carbohydrate with trypsin-pronase-treated whole cells as antigen. J. Clin. Microbiol. 26 (1988) 464
37. Vashishtha A., and Fischetti V.A. Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin. J. Immunol. 150 (1993) 4693
38. Waterboer T., Sehr P., and Pawlita M. Suppression of non-specific binding in serological Luminex assays. J. Immunol. Methods 309 (2006) 200-204
39. Wexler D.E., Chenoweth D.E., and Cleary P.P. Mechanism of action of the group A streptococcal C5a inactivator. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 8144